Virological characteristics of the SARS-CoV-2 JN.1 variant
- PMID: 38184005
- DOI: 10.1016/S1473-3099(23)00813-7
Virological characteristics of the SARS-CoV-2 JN.1 variant
Similar articles
-
As COVID-19 Cases Surge, Here's What to Know About JN.1, the Latest SARS-CoV-2 "Variant of Interest".JAMA. 2024 Feb 6;331(5):382-383. doi: 10.1001/jama.2023.27841. JAMA. 2024. PMID: 38214935
-
Anticipating the future of the COVID-19 pandemic: insights into the emergence of SARS-CoV-2 variant JN.1 and its projected impact on older adults.Geroscience. 2024 Jun;46(3):2879-2883. doi: 10.1007/s11357-024-01066-7. Epub 2024 Jan 10. Geroscience. 2024. PMID: 38198026 Free PMC article. No abstract available.
-
Clinical and virological features of asymptomatic and mild symptomatic patients with SARS-CoV-2 Omicron infection at Shanghai Fangcang shelter hospital.Immun Inflamm Dis. 2023 Sep;11(9):e1033. doi: 10.1002/iid3.1033. Immun Inflamm Dis. 2023. PMID: 37773703 Free PMC article.
-
Overview of immunological & virological factors driving the evolution & global spread of SARS-CoV-2 variants.Indian J Med Res. 2023 Sep;158(3):257-268. doi: 10.4103/ijmr.ijmr_2591_22. Indian J Med Res. 2023. PMID: 37815068 Free PMC article. Review.
-
The risk of mortality and severe illness in patients infected with the omicron variant relative to delta variant of SARS-CoV-2: a systematic review and meta-analysis.Ir J Med Sci. 2023 Dec;192(6):2897-2904. doi: 10.1007/s11845-022-03266-6. Epub 2023 Feb 9. Ir J Med Sci. 2023. PMID: 36754948 Free PMC article.
Cited by
-
Appearance and Prevalence of JN.1 SARS-CoV-2 Variant in India and Its Clinical Profile in the State of Maharashtra.Cureus. 2024 Mar 22;16(3):e56718. doi: 10.7759/cureus.56718. eCollection 2024 Mar. Cureus. 2024. PMID: 38646375 Free PMC article.
-
Two-Stage Mixed-Dye-Based Isothermal Amplification with Ribonuclease-Cleavable Enhanced Probes for Dual-Visualization Detection of SARS-CoV-2 Variants of Interest.Adv Sci (Weinh). 2024 Aug;11(29):e2401988. doi: 10.1002/advs.202401988. Epub 2024 Jun 3. Adv Sci (Weinh). 2024. PMID: 38829265 Free PMC article.
-
Structural basis and mode of action for two broadly neutralizing nanobodies targeting the highly conserved spike stem-helix of sarbecoviruses including SARS-CoV-2 and its variants.PLoS Pathog. 2025 Apr 11;21(4):e1013034. doi: 10.1371/journal.ppat.1013034. eCollection 2025 Apr. PLoS Pathog. 2025. PMID: 40215243 Free PMC article.
-
XBB.1.5 mRNA COVID-19 vaccine protection against inpatient or emergency department visits among adults infected with SARS-CoV-2 JN.1 and XBB-lineage variants.Front Immunol. 2025 Feb 17;16:1470609. doi: 10.3389/fimmu.2025.1470609. eCollection 2025. Front Immunol. 2025. PMID: 40034704 Free PMC article.
-
Beyond the Pandemic Era: Recent Advances and Efficacy of SARS-CoV-2 Vaccines Against Emerging Variants of Concern.Vaccines (Basel). 2025 Apr 17;13(4):424. doi: 10.3390/vaccines13040424. Vaccines (Basel). 2025. PMID: 40333293 Free PMC article. Review.
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous